Cristiane D Bergerot: Refining Health-Related Quality of Life Measurement in RCC
Cristiane D Bergerot, Director of the Department of Psycho-Oncology at CETTRO Cancer Research Hospital, shared a post on X:
“Excited to share our new paper European Urology Oncology! We developed patient-centered, stage-specific FKSI-23 tools to better capture HRQOL in localized abd metastatic RCC, moving beyond generic instruments to what truly matters to patients.
Deeply grateful to my mentors Tom Powles, Sumanta K. Pal for their mentorship and to our outstanding international expert team for shaping these tools. Special thanks to the patient advocates; FKSI-23 truly reflects what matters most to people living with RCC.
This study is a step toward more meaningful HRQOL measurement in RCC, with validation ongoing in future trials.”
Title: Development of a Health-related Quality of Life Questionnaire for Patients with Metastatic or Localized Renal Cell Carcinoma
Authors: Cristiane D. Bergerot, David Cella, Paulo G. Bergerot, Daniela V. Castro, Benjamin D. Mercier, Elizabeth Nally, Adil A. Ali, Errol J. Philip, Thomas Hutson, Axel Bex, Sarah P. Psutka, Brian Rini, Elizabeth R. Plimack, Viktor Grünwald, Viraj Master, Laurence Albiges, Toni K. Choueiri, Sumanta K. Pal, Thomas Powles,
More posts featuring Cristiane D Bergerot.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023